|
EP3219705B1
(en)
|
2005-12-28 |
2020-03-11 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions of the amorphous form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
TWI491606B
(zh)
|
2009-07-13 |
2015-07-11 |
Gilead Sciences Inc |
調節細胞凋亡信號之激酶的抑制劑
|
|
US9719068B2
(en)
|
2010-05-06 |
2017-08-01 |
Children's Hospital Medical Center |
Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
|
|
EP2545964A1
(en)
|
2011-07-13 |
2013-01-16 |
Phenex Pharmaceuticals AG |
Novel FXR (NR1H4) binding and activity modulating compounds
|
|
US11571431B2
(en)
|
2013-12-04 |
2023-02-07 |
Galmed Research And Development Ltd |
Aramchol salts
|
|
CN106661548B
(zh)
|
2014-05-28 |
2020-12-11 |
儿童医院医疗中心 |
用于经由定向分化将前体细胞转化为胃组织的方法和系统
|
|
JP6804438B2
(ja)
|
2014-10-17 |
2020-12-23 |
チルドレンズ ホスピタル メディカル センター |
多能性幹細胞を使用するヒト小腸のｉｎ ｖｉｖｏモデル、並びにそれを作製、及び使用する方法
|
|
KR101974793B1
(ko)
|
2015-07-06 |
2019-05-02 |
길리애드 사이언시즈, 인코포레이티드 |
Cot 조정제 및 그의 사용 방법
|
|
HUE053175T2
(hu)
|
2015-11-25 |
2021-06-28 |
Gilead Apollo Llc |
ACC-gátló észterek és azok alkalmazása
|
|
CA3004796C
(en)
*
|
2015-11-25 |
2023-11-14 |
Gilead Apollo, Llc |
Pyrazole acc inhibitors and uses thereof
|
|
IL243707A0
(en)
|
2016-01-20 |
2016-05-01 |
Galmed Res And Dev Ltd |
Treatment to regulate the microbiota in the intestine
|
|
CN119977993A
(zh)
|
2016-03-02 |
2025-05-13 |
吉利德阿波罗公司 |
噻吩并嘧啶二酮acc抑制剂的固体形式及其制备方法
|
|
ES2929758T3
(es)
|
2016-05-05 |
2022-12-01 |
Childrens Hospital Med Ct |
Métodos para la fabricación in vitro de tejido del fondo gástrico y composiciones relacionadas con el mismo
|
|
MX385718B
(es)
|
2016-06-13 |
2025-03-18 |
Gilead Sciences Inc |
Compuestos moduladores de fxr (nr1h4).
|
|
CA3252823A1
(en)
|
2016-06-13 |
2025-02-25 |
Gilead Sciences, Inc. |
Substituted tert-butyl-3-(2-chloro-phenyl)-3-hydroxyazetidine-1-carboxylate compounds
|
|
KR102729404B1
(ko)
|
2016-11-04 |
2024-11-14 |
칠드런즈 호스피탈 메디칼 센터 |
간 유사 장기 조성물 및 이를 제조 및 사용하는 방법
|
|
MA46786A
(fr)
*
|
2016-11-10 |
2019-09-18 |
Galmed Res And Development Ltd |
Inhibition de la fibrose chez des patients atteints d'une stéatose hépatique non alcoolique
|
|
IL311409A
(en)
*
|
2016-11-10 |
2024-05-01 |
Galmed Res And Development Ltd |
Use of Amcol for the treatment of fibrosis
|
|
US11197870B2
(en)
|
2016-11-10 |
2021-12-14 |
Galmed Research And Development Ltd |
Treatment for hepatic fibrosis
|
|
JP7068305B2
(ja)
|
2016-12-05 |
2022-05-16 |
チルドレンズ ホスピタル メディカル センター |
結腸オルガノイドならびにその作製方法および使用方法
|
|
ES2928773T3
(es)
|
2017-01-17 |
2022-11-22 |
Heparegenix Gmbh |
Inhibidores de proteína cinasas para fomentar la regeneración hepática o reducir o prevenir la muerte de hepatocitos
|
|
CN108341830B
(zh)
*
|
2017-01-22 |
2021-03-02 |
广东东阳光药业有限公司 |
噻吩并嘧啶衍生物及其在药物中的应用
|
|
CN110431144B
(zh)
*
|
2017-03-24 |
2022-08-05 |
浙江海正药业股份有限公司 |
氰基取代的杂芳基并嘧啶酮类衍生物及其制备方法和用途
|
|
PT3600309T
(pt)
*
|
2017-03-28 |
2022-10-03 |
Gilead Sciences Inc |
Combinações terapêuticas para o tratamento de doenças hepáticas
|
|
WO2018183342A1
(en)
*
|
2017-03-28 |
2018-10-04 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
AU2018250614A1
(en)
*
|
2017-04-12 |
2019-10-17 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
US12281334B2
(en)
|
2017-04-14 |
2025-04-22 |
Children's Hospital Medical Center |
Multi donor stem cell compositions and methods of making same
|
|
CN110536682B
(zh)
*
|
2017-04-18 |
2023-01-06 |
基恩菲特公司 |
依拉非诺或其衍生物与抗nash、抗纤维化或抗胆汁淤积药剂的组合
|
|
US11583570B2
(en)
*
|
2017-04-24 |
2023-02-21 |
Tsinghua University |
Use of autoinducer-related pathway in inducing apoptosis and anti-infective therapy
|
|
US20200129511A1
(en)
*
|
2017-06-19 |
2020-04-30 |
Arena Pharmaceuticals, Inc. |
Compounds and methods for treatment of nafld and nash
|
|
WO2019015583A1
(en)
|
2017-07-17 |
2019-01-24 |
Nanjing Ruijie Pharmatech Co., Ltd. |
NOVEL COMPOUNDS AND THEIR USES AS ACC INHIBITORS
|
|
WO2019020041A1
(zh)
*
|
2017-07-26 |
2019-01-31 |
南京圣和药业股份有限公司 |
作为acc抑制剂的化合物及其应用
|
|
CN109316601B
(zh)
*
|
2017-07-31 |
2021-11-09 |
武汉朗来科技发展有限公司 |
药物组合物及其用途
|
|
US11542256B2
(en)
|
2017-09-03 |
2023-01-03 |
Angion Biomedica Corp. |
Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors
|
|
US11033601B2
(en)
*
|
2017-09-14 |
2021-06-15 |
The Regents Of The University Of Colorado, A Body Corporate |
Selective inhibition of V1b for treating fatty liver
|
|
KR102419458B1
(ko)
|
2017-10-06 |
2022-07-12 |
길리애드 사이언시즈, 인코포레이티드 |
Acc 억제제를 포함하는 조합 요법
|
|
EP3694603B1
(en)
|
2017-10-10 |
2026-04-08 |
Children's Hospital Medical Center |
Esophageal tissue and/or organoid compositions and methods of making same
|
|
US11419918B2
(en)
*
|
2017-11-06 |
2022-08-23 |
Shenzhen Turier Biotech Co., Ltd. |
Treatment of biliary cirrhosis based on oxyntomodulin analogue GLP-1R/GCGR dual-target agonist peptide
|
|
CN107693514A
(zh)
*
|
2017-12-04 |
2018-02-16 |
威海贯标信息科技有限公司 |
一种鲁格列净组合物
|
|
US12379372B2
(en)
|
2017-12-21 |
2025-08-05 |
Children's Hospital Medical Center |
Digitalized human organoids and methods of using same
|
|
CA3089678A1
(en)
|
2018-01-31 |
2019-08-08 |
Heparegenix Gmbh |
Protein kinase mkk4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
|
|
US20210113561A1
(en)
*
|
2018-04-17 |
2021-04-22 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
|
CA3101274A1
(en)
*
|
2018-04-24 |
2019-10-31 |
Ph Pharma Co., Ltd. |
Use of neutrophil elastase inhibitors in liver disease
|
|
WO2019243315A1
(en)
|
2018-06-21 |
2019-12-26 |
Heparegenix Gmbh |
Tricyclic protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
|
|
US11912701B2
(en)
|
2018-07-16 |
2024-02-27 |
Heparegenix Gmbh |
Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
|
|
KR102887406B1
(ko)
|
2018-07-26 |
2025-11-19 |
칠드런즈 호스피탈 메디칼 센터 |
간-담도-췌장 조직 및 이를 제조하는 방법
|
|
US20210322324A1
(en)
*
|
2018-08-14 |
2021-10-21 |
Avolynt |
Method for treating primary sclerosing cholangitis
|
|
CR20210110A
(es)
|
2018-08-31 |
2021-05-13 |
Pfizer |
Combinaciones para tratamiento de ehna/ehgna y enfermedades relacionadas
|
|
JP2022500366A
(ja)
*
|
2018-09-06 |
2022-01-04 |
ガルメド リサーチ アンド ディベロップメント リミテッド |
肝疾患治療のための併用療法
|
|
AU2019339410A1
(en)
|
2018-09-12 |
2021-04-15 |
Children's Hospital Medical Center |
Organoid compositions for the production of hematopoietic stem cells and derivatives thereof
|
|
CN110950884B
(zh)
*
|
2018-09-27 |
2024-03-26 |
上海翰森生物医药科技有限公司 |
含二并环类衍生物抑制剂、其制备方法和应用
|
|
CA3119925A1
(en)
*
|
2018-11-20 |
2020-05-28 |
The National Institutes Of Pharmaceutical Research And Development (Nip) |
Spiro compound and medical uses thereof
|
|
EP3911647B1
(en)
|
2019-01-15 |
2023-12-13 |
Gilead Sciences, Inc. |
Isoxazole compound as fxr agonist and pharmaceutical compositions comprising same
|
|
WO2020160371A1
(en)
|
2019-02-01 |
2020-08-06 |
The University Of Hong Kong |
Innervated organoid compositions and methods of making same
|
|
CA3233305A1
(en)
|
2019-02-19 |
2020-08-27 |
Gilead Sciences, Inc. |
Solid forms of fxr agonists
|
|
CN113677336B
(zh)
*
|
2019-04-10 |
2024-04-30 |
基恩菲特公司 |
包含式(i)化合物和glp-1受体激动剂的组合疗法
|
|
GEP20247637B
(en)
|
2019-05-08 |
2024-06-25 |
Aligos Therapeutics Inc |
Modulators of thr-b and methods of use thereof
|
|
WO2020243613A1
(en)
|
2019-05-31 |
2020-12-03 |
Children's Hospital Medical Center |
Methods of generating and expanding hematopoietic stem cells
|
|
WO2020243633A1
(en)
|
2019-05-31 |
2020-12-03 |
Children's Hospital Medical Center |
Shaped organoid compositions and methods of making same
|
|
TWI770527B
(zh)
|
2019-06-14 |
2022-07-11 |
美商基利科學股份有限公司 |
Cot 調節劑及其使用方法
|
|
EP3995498A4
(en)
*
|
2019-07-02 |
2023-03-01 |
Sunshine Lake Pharma Co., Ltd. |
THIENOPYRIMIDI DERIVATIVES WITH STEREO CONFIGURATION AND THEIR USE IN MEDICINE
|
|
CA3148780A1
(en)
|
2019-07-29 |
2021-02-04 |
Bent PFAFFENROT |
Heteroaryl-substituted pyrazolo-pyridine protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
|
|
AR119594A1
(es)
|
2019-08-09 |
2021-12-29 |
Gilead Sciences Inc |
Derivados de tienopirimidina como inhibidores acc y usos de los mismos
|
|
CN110628810B
(zh)
*
|
2019-08-13 |
2022-06-28 |
浙江大学 |
一种提高植物光合效率的方法
|
|
KR102940806B1
(ko)
*
|
2019-08-30 |
2026-03-20 |
(주)셀트리온 |
피오글리타존, L-카르니틴 및 비페닐디메틸카르복실레이트를 포함하는 비알콜성 지방간염(NASH, Nonalcoholic Steatohepatitis) 치료 또는 예방을 위한 약학 조성물
|
|
US20230105984A1
(en)
|
2019-12-23 |
2023-04-06 |
Svetlana Marukian |
Compositions and methods for the treatment of liver diseases and disorders
|
|
AU2021207236A1
(en)
|
2020-01-15 |
2022-08-11 |
Heparegenix Gmbh |
3-benzoyl-1h-pyrrolo[2,3-b]pyridine derivatives as MKK4 inhibitors for treating liver diseases
|
|
JP2021134211A
(ja)
|
2020-02-24 |
2021-09-13 |
ファイザー・インク |
Ｎａｆｌｄ／ｎａｓｈおよび関連疾患の処置のための組合せ
|
|
JP2022058085A
(ja)
|
2020-02-24 |
2022-04-11 |
ファイザー・インク |
ジアシルグリセロールアシルトランスフェラーゼ２阻害剤とアセチル－ＣｏＡカルボキシラーゼ阻害剤との組合せ
|
|
CN115335055A
(zh)
*
|
2020-03-11 |
2022-11-11 |
东亚St株式会社 |
用于预防或治疗非酒精性脂肪性肝炎的药物组合物
|
|
AU2021249010B2
(en)
|
2020-03-30 |
2024-09-26 |
Gilead Sciences, Inc. |
Solid forms of (S)-6-(((1-(bicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)2-methyl-1-oxo-1,2- dihydroisoquinolin-5-yl)methyl)))amino)8-chloro-(neopentylamino)quinoline-3-carb onitrile a cot inhibitor compound
|
|
JP7446475B2
(ja)
|
2020-04-02 |
2024-03-08 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｃｏｔ阻害剤化合物を調製するためのプロセス
|
|
CN111407892A
(zh)
*
|
2020-04-08 |
2020-07-14 |
中国药科大学 |
Acsl4及其在nash中的应用
|
|
US11478533B2
(en)
|
2020-04-27 |
2022-10-25 |
Novo Nordisk A/S |
Semaglutide for use in medicine
|
|
US12521375B2
(en)
|
2020-05-21 |
2026-01-13 |
Shionogi & Co., Ltd. |
Pharmaceutical composition for treating fatty liver disease
|
|
EP4000616A1
(en)
*
|
2020-11-17 |
2022-05-25 |
Inventiva |
Combination therapy for the treatment of a liver disease
|
|
EP4304711A1
(en)
|
2021-03-11 |
2024-01-17 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
CA3214961A1
(en)
|
2021-03-29 |
2022-10-06 |
Gilead Sciences, Inc. |
Khk inhibitors
|
|
TW202304435A
(zh)
*
|
2021-06-04 |
2023-02-01 |
美商基利科學股份有限公司 |
治療ｎａｓｈ之方法
|
|
TW202311256A
(zh)
|
2021-06-18 |
2023-03-16 |
美商基利科學股份有限公司 |
用於治療ｆｘｒ誘發之搔癢之ｉｌ－３１調節劑
|
|
US20250006331A1
(en)
*
|
2021-08-31 |
2025-01-02 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Quantitative systems pharmacology methods for identifying therapeutics for disease states
|
|
WO2023047203A1
(en)
*
|
2021-09-25 |
2023-03-30 |
Torrent Pharmaceuticals Ltd |
Combination of omzotirome and antidiabetic agent, antihypertensive agent or anti-dyslipidemic agent
|
|
EP4434520A4
(en)
|
2021-11-19 |
2025-10-29 |
Shionogi & Co |
PHARMACEUTICAL PRODUCT FOR THE TREATMENT OF HEART DISEASE OR SKELETAL MUSCLE DISEASE
|
|
US20250017938A1
(en)
*
|
2023-06-20 |
2025-01-16 |
Sagimet Biosciences Inc. |
Combination therapies of fasn inhibitors with thyroid hormone receptor agonists
|
|
WO2025225969A1
(ko)
*
|
2024-04-22 |
2025-10-30 |
연세대학교 원주산학협력단 |
CCR2 억제제와 TGF-β 수용체 억제제의 병용투여를 통한 대사이상관련 지방간염 치료 방법
|